Psychotropic drugs and dopamine uptake inhibition.
D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D003864:Depression, Chemical; D004298:Dopamine / Q000378:metabolism*; D005277:Fenfluramine / Q000494:pharmacology; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D066298:In Vitro Techniques; D009638:Norepinephrine / Q000378:metabolism; D011619:Psychotropic Drugs / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013574:Synaptosomes / Q000378:metabolism; D013687:Telencephalon / Q000378:metabolism; D014149:Tranquilizing Agents / Q000494:pharmacology
D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D011619:Psychotropic Drugs; D014149:Tranquilizing Agents; D005277:Fenfluramine; D012701:Serotonin; D000547:Amantadine; D001058:Apomorphine; D004298:Dopamine; D009638:Norepinephrine